| 72 | 10 | 20 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:探究超声联合腹腔镜射频消融术(LRFA)对肝癌患者肝功能及免疫功能的影响。方法:选取我院收治的76例肝癌患者,随机分为治疗组及对照组各38例,治疗组采用超声联合LRFA治疗,对照组采用肝动脉栓塞化疗治疗,对比两组治疗前后肝功能和免疫功能指标的变化。结果:术后两组血清谷草转氨酶(AST)、谷丙转氨酶(ALT)、血清总胆红素(T-BIL)、直接胆红素(D-BIL)较术前显著下降(P<0.05),且术后两周治疗组下降程度显著低于对照组(P<0.05);术后两组血浆IgG、IgA和IgM水平明显高于术前(P<0.05),两组间比较差异显著(P<0.05);两组术后CD3+、CD4+、CD8+T淋巴细胞及NK细胞水平较术前均显著上升(P<0.05),CD4+/CD8+较术前有明显下降(P<0.05),且组间差异显著(P<0.05)。结论:超声联合LRFA治疗肝癌能有效保护患者的肝功能及免疫功能,可作为优选方案。
Abstract:Objective:To explore the effects of ultrasound in combined with laparoscopic radiofrequency ablation(LRFA)on the liver function and immunological function in patients with liver cancer.Methods:A total of 76 patients with liver cancer who were admitted in our hospital were included in the study and randomized into the treatment group and the control group with 38 cases in each group.The patients in the treatment group were given ultrasound in combined with LRFA,while the patients in the control group were given TACE.The changes of liver function and immunological function indicators before and after treatment in the two groups were compared.Results:The serum AST,ALT,T-BIL,and D-BIL after operation in the two groups were significantly reduced when compared with before operation(P<0.05);moreover,the reduced degree in the treatment group was significantly lower than that in the control group(P<0.05).The plasma IgG,IgA,and IgM levels after operation in the two groups were significantly elevated when compared with before operation(P<0.05),and the comparison between the two groups was statistically significant(P<0.05).CD3+,CD4+,CD8+,and NK levels after operation in the two groups were significantly elevated when compared with before operation(P<0.05),while CD4+/CD8+was significantly reduced when compared with before operation(P<0.05);moreover,the comparison between the two groups was statistically significant(P<0.05).Conclusions:Ultrasound in combined with LRFA in the treatment of liver cancer can protect the liver function and immunological function;therefore,it can be served as a preferred scheme.
1刘浩润,王观发,李为民,等.经腹腔镜联合腹腔镜超声射频消融治疗多发性肝癌的体会[J].临床消化病杂志,2013,25(2):98-100.
2 王涛,王伟峰,黄立军,等.射频及微波消融治疗与单纯化疗治疗中晚期非小细胞肺癌生活量的对比研究[J].现代生物医学进展,2013,13(12):2283-2288.
3 中国抗癌协会肝癌专业委员会,中国抗癌协会临床肿瘤学协作专业委员会,中华医学会肝病学分会肝癌学组.原发性肝癌规范化诊治专家共识[J].临床肿瘤学杂志,2009,14(3):259-269.
4 王文欢,郭汉斌,夏长虹,等.射频消融术对乙肝病毒相关性肝癌患者肝功能的影响[J].北京医学,2014,36(3):174-176.
5 薛平,郑超,曹良启,等.超声联合腹腔镜射频消融术对肝癌患者免疫功能的影响[J].临床医学工程,2012,19(10):1367-1640.
6 雷雅莉,郭熙锋,王丽萍,等.射频消融联合肝动脉栓塞化疗治疗原发性肝癌的系统评价[J].现代肿瘤医学,2013,21(6):1285-1288.
7 胡伟书.栓塞化疗联合射频消融治疗对42例晚期肝癌患者的近期疗效评价[J].胃肠病学和肝病学杂志,2014,23(5):491-493.
8 冯凯,马宽生,别平.射频消融技术在肝癌综合治疗中合理应用[J].中国实用外科杂志,2016,36(6):621-623.
基本信息:
DOI:10.13210/j.cnki.jhmu.20160927.002
中图分类号:R735.7;R445.1
引用信息:
[1]李新.超声联合腹腔镜射频消融术对肝癌患者肝功能及免疫功能的影响[J].海南医学院学报,2016,22(24):3046-3048.DOI:10.13210/j.cnki.jhmu.20160927.002.
基金信息:
铜川市科技支撑项目(sx20160302-23)~~
2016-09-27
2016-09-27
2016-09-27